Lee Hsin-Ju, Gau Chun-Chun, Lee Wan-Fang, Lee Wen-I, Huang Jing-Long, Chen Shih-Hsiang, Yeh Ho-Yu, Liang Chi-Jou, Fu Shih-Hang
Division of Allergy, Asthma, and Rheumatology, Department of Pediatrics, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Taoyuan, Taiwan.
Department of Pediatrics, Chang Gung Memorial Hospital, Keelung, Taiwan.
Front Pediatr. 2022 Apr 25;10:638549. doi: 10.3389/fped.2022.638549. eCollection 2022.
Patients with T cell deficiency <10% of normal proliferation are indicated to receive immune reconstruction by hematopoietic stem cell transplantation (HSCT). This study aimed to investigate whether non-radioactive assays can be used to quantitatively detect the lymphocyte proliferation <10% of normal as radioactive [H]-thymidine."
Radioactive [H]-thymidine, non-radioactive carboxyfluorescein diacetate succinimidyl ester (CFSE), and Ki-67 protein expressions were used to measure the lymphocyte proliferation as calculated using the stimulation index (SI), subtraction percentage, and proliferation index (FlowJo software). Normal references were established for comparison in the absence of parallel healthy controls.
Normal ranges of mitogen-stimulated lymphocyte proliferation were established as a SI of 15-267 (CSFE 47-92%, Ki-67 42-79%) with phytohemagglutinin (PHA) 5 μg/ml stimulation; 19-139 (CFSE 62-83%, 45-74% Ki-67) with concanavalin-A (ConA) 5 μg/ml stimulation; 7-53 (CFSE 6-23%, Ki-67 10-24%) with pokeweed mitogen (PWM) 0.1 ug/ml stimulation; 3-28 (CFSE 4-10%, Ki-67 5-14%) with candida 10 ug/ml stimulation; and 2-27 (CFSE 6-41%, Ki-67 6-30%) with bacille Calmette-Guerin (BCG) 0.02 ng/ml stimulation. The normalized CFSE-proliferation index was between 2.1 and 3.0. Although there was no significant correlation between these three assays in the healthy controls, the SI value for <10% [H]-thymidine proliferation in those with T cell deficiency was compatible with CFSE- and Ki-67-stained lymphocyte percentages, and validated in patients with , and mutations. When calculating [H]-thymidine <10% of normal lymphocyte proliferation, the threshold of parallel controls was more reliable than previously established normal references.
The large quantitative value of radioactive [H]-thymidine was more easily recognizable than that for non-radioactive CFSE and Ki-67. Even though the correlation was not significant, those identified to have <10% of normal proliferation by [H]-thymidine could be consistently detected by CFSE and Ki-67, and consequently indicated for HSCT.
T细胞增殖低于正常水平10%的T细胞缺陷患者,适合接受造血干细胞移植(HSCT)进行免疫重建。本研究旨在探讨非放射性检测方法是否可用于定量检测低于正常水平10%的淋巴细胞增殖情况,如同放射性[H] - 胸腺嘧啶核苷检测法。
使用放射性[H] - 胸腺嘧啶核苷、非放射性的羧基荧光素二乙酸琥珀酰亚胺酯(CFSE)以及Ki - 67蛋白表达来测量淋巴细胞增殖情况,通过刺激指数(SI)、扣除百分比和增殖指数(FlowJo软件)进行计算。在缺乏平行健康对照的情况下建立正常参考值用于比较。
建立了丝裂原刺激的淋巴细胞增殖正常范围,用5μg/ml植物血凝素(PHA)刺激时,SI为15 - 267(CFSE 47 - 92%,Ki - 67 42 - 79%);用5μg/ml刀豆蛋白A(ConA)刺激时,SI为19 - 139(CFSE 62 - 83%,Ki - 67 45 - 74%);用0.1μg/ml商陆丝裂原(PWM)刺激时,SI为7 - 53(CFSE 6 - 23%,Ki - 67 10 - 24%);用10μg/ml白色念珠菌刺激时,SI为3 - 28(CFSE 4 - 10%,Ki - 67 5 - 14%);用0.02ng/ml卡介苗(BCG)刺激时,SI为2 - 27(CFSE 6 - 41%,Ki - 67 6 - 30%)。标准化的CFSE增殖指数在2.1至3.0之间。尽管在健康对照中这三种检测方法之间无显著相关性,但T细胞缺陷患者中低于正常水平10%的[H] - 胸腺嘧啶核苷增殖的SI值与CFSE和Ki - 67染色的淋巴细胞百分比相符,并在有 、 和 突变的患者中得到验证。计算低于正常淋巴细胞增殖水平10%的[H] - 胸腺嘧啶核苷时,平行对照的阈值比先前建立的正常参考值更可靠。
放射性[H] - 胸腺嘧啶核苷的大量值比非放射性CFSE和Ki - 67更易于识别。尽管相关性不显著,但通过[H] - 胸腺嘧啶核苷鉴定为低于正常增殖水平10%的情况,可通过CFSE和Ki - 67一致检测到,因此可作为HSCT的指征。